The subsidiary of BGI headquarters in Shenzhen has over 100 genome sequencers and a cloud computing platform. It is dedicated to the genetic service-related industries such as prenatal diagnosis, personal genetic risk assessment, the pharmaceutical industry, anti-cancer drug screening, and personal health spectrum checks.
BGI press release, Occtober 28, 2013
BGI-Hong Kong 3730 Production Center begins operating, providing fast Sanger-type sequencing services